How to stage early BE cancer - EUS or endoscopic removal?

Similar documents
Histopathology of Endoscopic Resection Specimens from Barrett's Esophagus

Endoscopic UltraSound (EUS) Endoscopic Mucosal Resection (EMR) Moishe Liberman Director C.E.T.O.C.

Quiz Adenocarcinoma of the distal stomach has been increasing in the last 20 years. a. True b. False

ESD for EGC with undifferentiated histology

Tumor location is a risk factor for lymph node metastasis in superficial Barrett s adenocarcinoma

Is Endoscopic Ultrasound (EUS) necessary in the pre-therapeutic assessment of Barrett s esophagus with early neoplasia?

How to remove BE cancer: EMR or ESD? Expected outcome

Treatment Strategy for Non-curative Resection of Early Gastric Cancer. Jun Haneg Lee. Sungkyunkwan University, Samsung Medical Center, Seoul Korea

Paris classification (2003) 삼성의료원내과이준행

Esophageal Cancer. Wesley A. Papenfuss MD FACS Surgical Oncology Aurora Cancer Care. David Demos MD Thoracic Surgery Aurora Cancer Care

Exploring diagnostic and therapeutic implications of endoscopic mucosal resection in EUS-staged T2 esophageal adenocarcinoma

Gregory G. Ginsberg, M.D.

Barrett s Esophagus: Ablate Everyone?

A Proposed Strategy for Treatment of Superficial Carcinoma. in the Thoracic Esophagus Based on an Analysis. of Lymph Node Metastasis

Barrett s Esophagus. Abdul Sami Khan, M.D. Gastroenterologist Aurora Healthcare Burlington, Elkhorn, Lake Geneva, WI

Endoscopic Submucosal Dissection ESD

How to treat early gastric cancer? Endoscopy

Superficial Esophageal Neoplasms Overlying Leiomyomas Removed by Endoscopic Submucosal Dissection: Case Reports and Review of the Literature

Barrett s Esophagus: Old Dog, New Tricks

malignant polyp Daily Challenges in Digestive Endoscopy for Endoscopists and Endoscopy Nurses BSGIE Annual Meeting 18/09/2014 Mechelen

Philip Chiu Associate Professor Department of Surgery, Prince of Wales Hospital The Chinese University of Hong Kong

Current status of gastric ESD in Korea. Jun Haeng Lee. Department of Medicine Sungkyunkwanuniversity School of Medicie, Seoul, Korea

Management of Barrett s: From Imaging to Resection

Esophageal cancer: Biology, natural history, staging and therapeutic options

Barrett s Esophagus: What to Do for No Dysplasia, LGD, and HGD?

Learning Objectives:

HHS Public Access Author manuscript Clin Gastroenterol Hepatol. Author manuscript; available in PMC 2017 March 01.

COLLECTING CANCER DATA: STOMACH AND ESOPHAGUS

Earlyoesophagealcancer. dr. Nina Zidar Institute of Pathology Faculty ofmedicine University of Ljubljana Slovenia

Barrett s esophagus. Barrett s neoplasia treatment trends

Risk factors for lymph node metastasis in histologically poorly differentiated type early gastric cancer

Current Management: Role of Radiofrequency Ablation

Frozen Section Analysis of Esophageal Endoscopic Mucosal Resection Specimens in the Real-Time Management of Barrett s Esophagus

Endoscopic Ultrasonography Assessment for Ampullary and Bile Duct Malignancy

EMR, ESD and Beyond. Peter Draganov MD. Professor of Medicine Division of Gastroenterology, Hepatology and Nutrition University of Florida

Barrett esophagus. Bible class Inselspital

American Journal of Gastroenterology. Volumetric Laser Endomicroscopy Detects Subsquamous Barrett s Adenocarcinoma

Staging Accuracy of Computed Tomography and Endoscopic Ultrasound in Preoperative Staging of Esophageal Cancer: Results of an Referral Center

Barrett Esophagus - RadioFrequency Ablation (BE-RFA) - Project manual + FAQ

Editorial: Advanced endoscopic therapeutics in Barrett s neoplasia; where are we now and where are we heading?

AGA SECTION. Gastroenterology 2016;150:

Joel A. Ricci, MD SUNY Downstate Medical Center Department of Surgery

Hong Kong Society of Upper Gastrointestinal Surgeons CLINICAL MEETING 29 NOV 2012

Subepithelial Lesions of the Gut: When Should I Worry?

The prognosis for patients treated for intra- and submucosal

Original articledote_1350. S. P. Mehta, 1 P. Jose, 1,2 A. Mirza, 3 S. A. Pritchard, 3 J. D. Hayden, 1 and H. I. Grabsch 2

RFA and Cyrotherapy for Esophageal Disease

Principles of diagnosis, work-up and therapy The Gastroenterologist s role

7/20/2017. Esophageal Cancer: A Less Common But Deadly Cancer. Objectives. Disclosure Statement NYNPA Conference October Saratoga New York

Definition of GERD American College of Gastroenterology

Citation for published version (APA): Phoa, K. Y. N. (2014). Endoscopic management of Barrett s esophagus with dysplasia

Diagnostic accuracy of pit pattern and vascular pattern in colorectal lesions

MANAGEMENT OF BARRETT S RELATED NEOPLASIA IN 2018

B Barrett neoplasia, early, endoscopic mucosal resection of, in Europe, 297

Factors for Endoscopic Submucosal Dissection in Early Colorectal Neoplasms: A Single Center Clinical Experience in China

Case Scenario 1. The patient has now completed his neoadjuvant chemoradiation and has been cleared for surgery.

ESOPHAGEAL CANCER. Epidemiology 3/22/2017. Esophageal Carcinoma: subtypes. Esophageal Adenocarcinoma (EAC) Epidemiology.

Endoscopic resection (ER) is becoming increasingly established ALIMENTARY TRACT

Key words: gastric cancer, lymphovascular invasion, recurrence

Oesophagus and Stomach update dysplasia and early cancer

Composite neuroendocrine carcinoma and squamous cell carcinoma with regional lymph node metastasis: a case report

Characteristics of intramural metastasis in gastric cancer. Tatsuya Hashimoto Kuniyoshi Arai Yuichi Yamashita Yoshiaki Iwasaki Tsunekazu

Present Day Management of Barrett s Esophagus

Minimally Invasive Esophagectomy: OVERRATED!!! Sagar Damle UCHSC December 11, 2006

Case Scenario year-old white male presented to personal physician with dyspepsia with reflux.

Gastric Cancer Histopathology Reporting Proforma

Management of pt1 polyps. Maria Pellise

Question: If in a particular case, there is doubt about the correct T, N or M category, what do you do?

Stage 1 esophageal cancer survival rate

History. Prevalence at Endoscopy. Prevalence and Reflux Sx. Prevalence at Endoscopy. Barrett s Esophagus: Controversy and Management

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

Esophagectomy for T1 Esophageal Cancer: Outcomes in 100 Patients and Implications for Endoscopic Therapy

Minimally Invasive Esophagectomy- Valuable. Jayer Chung, MD University of Colorado Health Sciences Center December 11, 2006

Key words: diagnosis for depth of invasion of esophageal cancer, endoscopic ultrasonography, submucosal esophagography, esophageal cancer

Endoscopic Ultrasonography Clinical Impact. Giancarlo Caletti. Gastroenterologia Università di Bologna. Caletti

Esophageal Cancer Staging Essentials: The New TNM Staging System (7th edition) and Clinicoradiologic Implications

Nakamura et al. BMC Cancer (2016) 16:743 DOI /s y

New Developments in the Endoscopic Diagnosis and Management of Barrett s Esophagus

Research Article Analysis of Predictors for Lymph Node Metastasis in Patients with Superficial Esophageal Carcinoma

Greater Manchester & Cheshire Guidelines for Pathology Reporting for Oesophageal and Gastric Malignancy

Michael A. Choti, MD, FACS Department of Surgery Johns Hopkins Medicine, Baltimore, MD

Everything Esophagus: Barrett s Esophagus. Nicholas Shaheen, MD, MPH Center for Esophageal Diseases and Swallowing University of North Carolina

ESOPHAGEAL CANCER AND GERD. Prof Salman Guraya FRCS, Masters MedEd

Endoscopic imaging modalities for diagnosing invasion depth of superficial esophageal squamous cell carcinoma: a systematic review and meta-analysis

Diagnosis and staging of superficial esophageal precursor based on pre-endoscopic resection system comparable to endoscopic resection

T2N0 Esophageal Cancer: Does it Exist? Should we give Preop Therapy?

위암내시경진단 (2019) - 융기형위암을중심으로 성균관대학교의과대학내과이준행

Esophageal carcinoma is a significant worldwide health

Metachronous Esophageal Cancer and Colon Cancer Treated by Endoscopic Mucosal Resection

Newly Diagnosed Cases Cancer Related Death NCI 2006 Data

Decision making in stage-directed therapy of esophageal cancer is easy at the. T2N0M0 esophageal cancer GTS

Impact of a dedicated multidisciplinary meeting on the management of superficial cancers of the digestive tract

The Pathologist s Role in the Diagnosis and Management of Neoplasia in Barrett s Oesophagus Cian Muldoon, St. James s Hospital, Dublin

Natural history of early gastric cancer: series of 21 cases

University Mainz. Early Gastric Cancer. Ralf Kiesslich. Johannes Gutenberg University Mainz, Germany. Early Gastric Cancer 15.6.

Tumours of the Oesophagus & Gastro-Oesophageal Junction Histopathology Reporting Proforma

ACG Clinical Guideline: Diagnosis and Management of Barrett s Esophagus

Introduction. Piecemeal EMR (EPMR) Symposium

Ablation for Barrett s Esophagus: Burn or Freeze

Extensive (8 to 12 cm 2 ) Noncircumferential Endoscopic Mucosal Resection for Early Esophageal Cancer

Transcription:

How to stage early BE cancer - EUS or endoscopic removal? Presented by Bas Weusten Institution St. Antonius Hospital, Nieuwegein Academic Medical Center, Amsterdam

case 56 y old female patient Lung transplant in 2013 Upper GI endoscopy for dyspepsia Bx: carcinoma EUS for staging?

Question Would you perform EUS for staging of this cancer Answer 1: yes Answer 2: no

Staging of early BE cancer Why? Questions to be answered in early BE cancer Is endoscopic therapy possible? Will endoscopic therapy be curative?

Will endoscopic therapy be curative? Endoscopic Tx is only justified if probability of LNM perioperative surgical mortality

Early BE cancer determinants of risk of LNMs Depth of invasion Tumor differentiation Invasion into (lymph)vessels Most determinants can only be assessed on histopathology of the resection specimen Potential role of EUS: - Depth of invasion - Lymph nodes?

Early BE cancer determinants of risk of LNMs Depth of tumor invasion T1A T1B m1 m2 m3 sm1 sm2 sm3 500 μm 1000 μm ep lp mm sm Endoscopic Can EUS reliably therapy predict for mucosal depth (sm1?) of tumor tumors invasion? only* *Pech et al. Gastroenterology 2014;146:652-60 Manner et al. Surg Endosc 2015;29:1888-96

EUS for (early) BE cancer literature year journal 1st author EUS beneficial? 2004 GUT May + 2005 GIE Larghi +/- 2008 Endoscopy Chemaly - 2010 Endoscopy Pech - 2010 Surg Endoscopy Thomas - 2011 GIE Pouw - 2011 Ann Thorac Surg Crabtree - 2012 J Gastrointest Oncol Fernandez-Sordo - 2014 Dis Esophagus Bulsiewicz - 2014 J Thorac Cardiovasc Surg Bergeron -

EUS for T staging in esophageal cancer Esophageal Cancer N=179 Barrett s cancer n=134 (75%) Squamous cell cancer n=45 (25%) Endoscopic Ultrasonography Surgical Esophageal Resection Pech et al. Endoscopy 2010;42:456-61

EUS staging EUS for T staging in esophageal cancer Histopathological staging pt1 pt2 pt3 pt4 Total (n) EUS T1 88 EUS T2 35 EUS T3 56 EUS T4 Total (n) 99 30 46 4 179 Pech et al. Endoscopy 2010;42:456-61

EUS staging EUS for T staging in esophageal cancer Histopathological staging pt1 pt2 pt3 pt4 Total (n) EUS T1 81 3 4-88 EUS T2 17 13 4 1 35 EUS T3 1 14 38 3 56 EUS T4 - - - - Total (n) 99 30 46 4 179 Pech et al. Endoscopy 2010;42:456-61

EUS staging EUS for T staging in esophageal cancer Histopathological staging pt1 pt2 pt3 pt4 Total (n) EUS T1 81 3 4-88 EUS T2 17 13 4 1 35 EUS T3 1 14 38 3 56 EUS T4 - - - - Total (n) 99 30 46 4 179 overstaged 18% 46,7% - - understaged 10,0% 17,4% 100% Pech et al. Endoscopy 2010;42:456-61

EUS staging EUS for T staging in esophageal cancer Histopathological staging pt1 pt2 pt3 pt4 Total (n) % correct EUS T1 81 3 4-88 92% EUS T2 17 13 4 1 35 37% EUS T3 1 14 38 3 56 68% EUS T4 - - - - Total (n) 99 30 46 4 179 74% overstaged 18% 46,7% - - understaged 10,0% 17,4% 100% Pech et al. Endoscopy 2010;42:456-61

Early Barrett s cancer: role of EUS Early Barrett s cancer n=131 EUS unremarkable n=105 (80%) Endoscopic Resection No indication for surgery 76% (n=80) Indication for surgery 24% (n=25) Pouw et al. GIE 2011;73:662-8

Early Barrett s cancer: role of EUS Early Barrett s cancer n=131 EUS suspicious n=26 (20%) Endoscopy unremarkable 54% (n=14) ER No indication for surgery 50% (n=7) Indication for surgery 50% (n=7) Pouw et al. GIE 2011;73:662-8 Endoscopy suspicious 46% (n=12) ER No indication for surgery 25% (n=3) Indication for surgery 75% (n=9)

Early Barrett s cancer: role of EUS Pouw et al. GIE 2011;73:662-8

How to stage early BE cancer - EUS or endoscopic removal? CONCLUSION I: EUS is unreliable in the assessment of depth of tumor invasion in early BE cancer.

EUS for N staging in esophageal cancer Esophageal Cancer N=179 Barrett s cancer n=134 (75%) Squamous cell cancer n=45 (25%) Endoscopic Ultrasonography Surgical Esophageal Resection Pech et al. Endoscopy 2010;42:456-61

EUS staging EUS for N staging in esophageal cancer Histopathological staging pn0 pn1 Total (n) EUS N0 102 EUS N1 77 Total (n) 111 68 179 Pech et al. Endoscopy 2010;42:456-61

EUS staging EUS for N staging in esophageal cancer Histopathological staging pn0 pn1 Total (n) EUS N0 82 20 102 EUS N1 29 48 77 Total (n) 111 68 179 Pech et al. Endoscopy 2010;42:456-61

EUS staging EUS for N staging in esophageal cancer Histopathological staging pn0 pn1 Total (n) EUS N0 82 20 102 EUS N1 29 48 77 Total (n) 111 68 179 overstaged 26% - understaged 29% Pech et al. Endoscopy 2010;42:456-61

EUS staging EUS for N staging in esophageal cancer Histopathological staging pn0 pn1 Total (n) % correct EUS N0 82 20 102 80% EUS N1 29 48 77 62% Total (n) 111 68 179 73% overstaged 26% - understaged 29% Pech et al. Endoscopy 2010;42:456-61

How to stage early BE cancer - EUS or endoscopic removal? CONCLUSION I: EUS is unreliable in the assessment of depth of tumor invasion in early BE cancer. CONCLUSION II: EUS is not reliably enough in the assessment of LNM in early BE cancer Early BE cancer should be staged by means of histopathological analysis of the endoscopic resection specimen

case 56 y old female patient Lung transplant in 2013 Upper GI endoscopy for dyspepsia Bx: carcinoma EUS for staging?

Question Would you perform EUS for staging of this cancer Answer 1: yes Answer 2: no

How to stage early BE cancer - EUS or endoscopic removal? Practical guidence If a lesion appears to be resectable by ER, just do it If a lesion invades into the muscularis propria MBM the band will simpy fall off EMR-cap non-lifting sign Histopathology of the resection specimen will guide you on further management Low-risk and R0-resection endoscopic management High-risk and/or R1-resection consider surgery

case Histopathology: T1m3 G1-2 LVI-